Fine Foods & Pharmaceuticals N.T.M. S.p.A. risk profile
40 Elevated one input has moved against it
Measured 1 September 2026 from 9S5's filed statements. Recomputed nightly.
40 (Elevated), driven by Market expectation at 61, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 61 | Stretched | Stable | Average daily turnover — $110 |
| Operating pressure | 37 | Normal | Worsening | Costs outgrowing revenue — -0.6 percentage points |
| Cash conversion | 49 | Elevated | Worsening | Capital spending against operating cash — 1.09x |
| Leverage and coverage | 24 | Normal | Easing | Current ratio — 1.75x |
| Competitive position | 42 | Elevated | Stable | Operating-margin gap against peers — +2.0 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for Fine Foods & Pharmaceuticals N.T.M. S.p.A.